Pfizer Stock News

More positive cannabis drug trial results for Alzheimer''s patients were released

Good Life Advisors LLC grew its holdings in Pfizer Inc. (NYSE:PFE) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 31,812 shares of the biopharmaceutical companys stock after purchasing an additional 1,648 shares during the quarter. Good Life Advisors LLCs holdings []

Pfizer and BioNtech announced Friday they will test a third dose of their COVID-19 vaccine in children 5 and younger.

vaccine data for younger children delayed Pfizer Inc (PFE.N) on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization. Pfizer Chief Scientific Officer Mikael Dolsten said in a presentation to investors []

Pfizer Inc. said it is testing a three-dose course of the COVID-19 vaccine in all age groups under 16, including two to four-year-olds.

Japanese Prime Minister Fumio Kishida said Friday his government is seeking to accelerate its COVID-19 booster shots campaign and has reached out to the head of U.S. pharmaceutical company Pfizer to secure additional vaccines. Kishida told reporters the government has been negotiating to receive 120 million doses of Pfizer''s COVID-19 vaccine ahead of schedule. He said during his call with the company''s CEO, Alber

Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.

Pfizer said Friday it was changing plans and testing three doses of its Covid-19 vaccine in babies and preschoolers instead of the usual two.

Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers instead of the usual two.

Hudson Value Partners LLC increased its stake in Pfizer Inc. (NYSE:PFE) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,481 shares of the biopharmaceutical companys stock after buying an additional 300 shares during the quarter. Hudson Value Partners []

According to new research study on Global Tyrosine Kinase Inhibitors Market 2027 covers worldwide, provincial, and nation level market size, pieces of the overall industry, market development rate investigation (incorporate Reason of most noteworthy and least pinnacle Market examination), ongoing

The agency said it has a clinical preference for the Pfizer and Moderna vaccines.

36,188 doses of Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccines were administered in the last 24 hours, of which 7,427 were first doses, 10,424 second doses and 18,337 third doses, the National Committee Coordinating Activities on Vaccination against COVID-19 (CNCAV) Citește mai departe…

Northstar Asset Management LLC grew its stake in Pfizer Inc. (NYSE:PFE) by 1.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 25,717 shares of the biopharmaceutical companys stock after acquiring an additional 250 shares during the period. Northstar Asset Management LLCs holdings in Pfizer were worth []